INVO Fertility (IVF) Operating Income (2011 - 2026)

INVO Fertility (IVF) has reported Operating Income for 16 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Operating Income fell 32.63% year-over-year to -$1.6 million in Q1 2026; TTM through Mar 2026 was -$7.6 million, a 20.72% decrease from a year earlier, with the FY2025 full-year figure at -$7.2 million, down 9.2% from the prior year.
• Operating Income was -$1.6 million for Q1 2026 at INVO Fertility, down from -$1.4 million in the prior quarter.
• Over five years, Operating Income peaked at -$886290.0 in Q3 2023 and troughed at -$3.0 million in Q2 2025.
• A 5-year average of -$1.9 million and a median of -$1.9 million in 2024 frame the typical range for Operating Income.
• Across the five-year window, Operating Income tumbled 639.82% in 2022 and surged 64.91% in 2023, its largest moves.
• Over 5 years, Operating Income stood at -$2.7 million in 2022, then surged by 44.51% to -$1.5 million in 2023, then sank by 30.35% to -$2.0 million in 2024, then gained by 28.18% to -$1.4 million in 2025, then dropped by 12.65% to -$1.6 million in 2026.
• The last three Operating Income figures came in at -$1.6 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.